Hallal David

Chief Executive Officer | CEO | Director +1 more

3 companies

Insider Signal Score

Excellent

Trades Analyzed

12M Win Rate

87.5%

Avg 3M Return

+2.3%

Avg 12M Return

+39.5%

Hallal David is a Director, 10% Owner at Kalaris Therapeutics, Inc. with holdings across 3 companies. Recent SEC Form 4 filings include 0 buys and 9 sells.

Estimated insider holdings value: $83.7M based on current market prices.

Holdings by Company

KLRSJun 6, 2024

Current Shares2.14M

Value$10.12M

Net Activity-1,157,004

Bought: 0Sold: 1.16M

SRRKJan 13, 2026

Current Shares1.54M

Value$72.97M

Net Activity-57,450

Bought: 0Sold: 57.5K

SEERJun 12, 2024

Current Shares355.1K

Value$617.9K

Net Activity0

Bought: 0Sold: 0

Transaction History

Showing 8 filings

Date	Ticker	Role	Type	Shares	Price	Value	Chg%	3M	12M
Jan 13, 2026	SRRK Scholar Rock Holding Corp	Chief Executive Officer	Sell	57,450	$42.70	$2,453,115.00	-3.6%	+14.2%	-
Oct 19, 2022	KLRS Kalaris Therapeutics, Inc.	Director, 10% Owner	Sell	600,000	$8.45	$5,070,000.00	-81.3%	-40.8%	-83.6%
Sep 29, 2022	KLRS Kalaris Therapeutics, Inc.	Director, 10% Owner	Sell	400,000	$7.35	$2,940,920.00	-35.7%	-40.1%	-72.6%
Jul 21, 2022	KLRS Kalaris Therapeutics, Inc.	Director, 10% Owner	Sell	4,227	$5.33	$22,527.80	-0.2%	+78.8%	-33.7%
Jun 3, 2022	KLRS Kalaris Therapeutics, Inc.	Director, 10% Owner	Sell	65,725	$3.67	$241,105.59	-3.1%	+102.7%	+7.0%
Apr 21, 2022	KLRS Kalaris Therapeutics, Inc.	Director, 10% Owner	Sell	4,227	$5.87	$24,812.49	-0.2%	-1.7%	-29.0%
Mar 11, 2022	KLRS Kalaris Therapeutics, Inc.	Director, 10% Owner	Sell	65,725	$7.48	$491,849.80	-1.5%	-45.4%	-33.7%
Jan 24, 2022	KLRS Kalaris Therapeutics, Inc.	Director, 10% Owner	Sell	17,100	$8.01	$136,888.92	-0.8%	-40.1%	-34.3%